<table frame="void" id="INV-35b78f1c-4a88-402f-9b44-84acf55605a7" xmlns="urn:hl7-org:v3" xmlns:voc="urn:hl7-org:v3/voc" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col width="96px"></col>
<col width="112px"></col>
<col width="148px"></col>
<col width="148px"></col>
<col width="108px"></col>
<tbody>
<tr>
<td align="center" colspan="5" stylecode="Botrule">
<content stylecode="bold"> AZITHROMYCIN CONCENTRATIONS FOLLOWING A500 mg DOSE (TWO 250 mg CAPSULES) IN ADULTS </content>
</td>
</tr>
<tr>
<td align="center" stylecode="Botrule">
<content stylecode="bold"> TISSUE OR FLUID </content>
</td>
<td align="center" stylecode="Botrule">
<content stylecode="bold"> TIME AFTER DOSE (h) </content>
</td>
<td align="center" stylecode="Botrule">
<content stylecode="bold"> TISSUE OR FLUID CONCENTRATION (mcg/g or mcg/mL) </content>
</td>
<td align="center" stylecode="Botrule">
<content stylecode="bold"> CORRESPONDING PLASMA OR SERUM LEVEL (mcg/mL) </content>
</td>
<td align="center" stylecode="Botrule">
<content stylecode="bold">TISSUE (FLUID) PLASMA (SERUM) RATIO</content>
<sup>1</sup>
</td>
</tr>
<tr>
<td stylecode="Botrule"> SKIN </td>
<td align="center" stylecode="Botrule"> 72-96 </td>
<td align="center" stylecode="Botrule"> 0.4 </td>
<td align="center" stylecode="Botrule"> 0.012 </td>
<td align="center" stylecode="Botrule"> 35 </td>
</tr>
<tr>
<td stylecode="Botrule"> LUNG </td>
<td align="center" stylecode="Botrule"> 72-96 </td>
<td align="center" stylecode="Botrule"> 4 </td>
<td align="center" stylecode="Botrule"> 0.012 </td>
<td align="center" stylecode="Botrule"> &gt;100 </td>
</tr>
<tr>
<td stylecode="Botrule">SPUTUM
                        <sup>*</sup>
</td>
<td align="center" stylecode="Botrule">
 2-4 </td>
<td align="center" stylecode="Botrule"> 1</td>
<td align="center" stylecode="Botrule"> 0.64 </td>
<td align="center" stylecode="Botrule"> 2 </td>
</tr>
<tr>
<td stylecode="Botrule">SPUTUM
                        <sup>**</sup>
</td>
<td align="center" stylecode="Botrule"> 10-12 </td>
<td align="center" stylecode="Botrule"> 2.9 </td>
<td align="center" stylecode="Botrule"> 0.1 </td>
<td align="center" stylecode="Botrule"> 30 </td>
</tr>
<tr>
<td stylecode="Botrule">TONSIL
                        <sup>***</sup>
</td>
<td align="center" stylecode="Botrule"> 9-18 </td>
<td align="center" stylecode="Botrule"> 4.5 </td>
<td align="center" stylecode="Botrule"> 0.03 </td>
<td align="center" stylecode="Botrule"> &gt;100 </td>
</tr>
<tr>
<td stylecode="Botrule">TONSIL
                        <sup>***</sup>
</td>
<td align="center" stylecode="Botrule"> 180 </td>
<td align="center" stylecode="Botrule"> 0.9 </td>
<td align="center" stylecode="Botrule"> 0.006 </td>
<td align="center" stylecode="Botrule"> &gt;100 </td>
</tr>
<tr>
<td stylecode="Botrule">CERVIX
                        <sup>****</sup>
</td>
<td align="center" stylecode="Botrule">
 19 </td>
<td align="center" stylecode="Botrule"> 2.8 </td>
<td align="center" stylecode="Botrule"> 0.04 </td>
<td align="center" stylecode="Botrule"> 70 </td>
</tr>
<tr>
<td colspan="5" stylecode="Botrule">
<sup>1 </sup>High tissue concentrations should not be interpreted to be quantitatively related to clinical efficacy. The antimicrobial activity of azithromycin is pH related and appears to be reduced with decreasing pH. However, the extensive distribution of drug to tissues may be relevant to clinical activity.
                      </td>
</tr>
<tr>
<td colspan="5" stylecode="Botrule"> *    Sample was obtained 2 to 4 hours after the first dose. </td>
</tr>
<tr>
<td colspan="5" stylecode="Botrule"> **    Sample was obtained 10 to 12 hours after the first dose. </td>
</tr>
<tr>
<td colspan="5" stylecode="Botrule"> ***   Dosing regimen of 2 doses of 250 mg each, separated by 12 hours.  </td>
</tr>
<tr>
<td colspan="5" stylecode="Botrule"> ****  Sample was obtained 19 hours after single 500 mg dose. </td>
</tr>
</tbody>
</table>